CRNX Crinetics Pharmaceuticals In

held by 1 manager in Q3 2024

Manager	% of their portfolio	Held	Activity	Value	Shares
Stanley Druckenmiller Duquesne Family Office	0.55%	9 mo	—	$16M	309,000

Search